162 related articles for article (PubMed ID: 23109819)
1. Combined treatment with an oncolytic adenovirus and antitumor activity of vincristine against retinoblastoma cells.
Song X; Wang H; Jia R; Cun B; Zhao X; Zhou Y; Xu X; Qian G; Ge S; Fan X
Int J Mol Sci; 2012; 13(9):10736-10749. PubMed ID: 23109819
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.
Song X; Zhou Y; Jia R; Xu X; Wang H; Hu J; Ge S; Fan X
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2626-35. PubMed ID: 20007825
[TBL] [Abstract][Full Text] [Related]
3. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
4. Low concentrations of chloroquine and 3-methyladenine suppress the viability of retinoblastoma cells synergistically with vincristine independent of autophagy inhibition.
Zheng XY; Li LJ; Li W; Jiang PF; Shen HQ; Chen YH; Chen X
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2309-15. PubMed ID: 26335535
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model.
Ji X; Zhang J; Cheng L; Wei F; Li H; Liu X; Chen X; Li C; Wang Y; Huang Q
Exp Eye Res; 2009 Aug; 89(2):193-9. PubMed ID: 19328781
[TBL] [Abstract][Full Text] [Related]
6. A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers.
Wang X; Su C; Cao H; Li K; Chen J; Jiang L; Zhang Q; Wu X; Jia X; Liu Y; Wang W; Liu X; Wu M; Qian Q
Mol Cancer Ther; 2008 Jun; 7(6):1598-603. PubMed ID: 18566230
[TBL] [Abstract][Full Text] [Related]
7. microRNA-222-Mediated VHL Downregulation Facilitates Retinoblastoma Chemoresistance by Increasing HIF1α Expression.
Li C; Zhao J; Sun W
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):9. PubMed ID: 32756923
[TBL] [Abstract][Full Text] [Related]
8. Constitutively active Akt contributes to vincristine resistance in human retinoblastoma cells.
Zhang H; Li B; Bai SW; Wang HJ
Cancer Invest; 2010 Feb; 28(2):156-65. PubMed ID: 19968493
[TBL] [Abstract][Full Text] [Related]
9. Silencing of lncRNA XIST suppresses proliferation and autophagy and enhances vincristine sensitivity in retinoblastoma cells by sponging miR-204-5p.
Yao L; Yang L; Song H; Liu TG; Yan H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3526-3537. PubMed ID: 32329826
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Sreenivasan S; Krishnakumar S
Curr Eye Res; 2015; 40(11):1153-65. PubMed ID: 25495096
[TBL] [Abstract][Full Text] [Related]
11. Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block.
Cun B; Song X; Jia R; Zhao X; Wang H; Ge S; Fan X
Cancer Biol Ther; 2012 Jan; 13(2):77-84. PubMed ID: 22336909
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis.
Fu K; Zhang K; Zhang X
Orphanet J Rare Dis; 2022 Mar; 17(1):119. PubMed ID: 35248107
[TBL] [Abstract][Full Text] [Related]
13. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
14. CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy.
Sun J; Feng D; Xi H; Luo J; Zhou Z; Liu Q; Chen Y; Shao Q
Mol Oncol; 2020 Aug; 14(8):1740-1759. PubMed ID: 32394616
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus.
Koch J; Schober SJ; Hindupur SV; Schöning C; Klein FG; Mantwill K; Ehrenfeld M; Schillinger U; Hohnecker T; Qi P; Steiger K; Aichler M; Gschwend JE; Nawroth R; Holm PS
Nat Commun; 2022 Aug; 13(1):4689. PubMed ID: 35948546
[TBL] [Abstract][Full Text] [Related]
16. [Arsenic trioxide induced apoptosis in retinoblastoma cells in vitro and its possible mechanism].
Li Y; Tang LS; Shen HW
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 33(6):476-80. PubMed ID: 18599993
[TBL] [Abstract][Full Text] [Related]
17. miR-130a-3p Enhances the Chemosensitivity of Y79 Retinoblastoma Cells to Vincristine by Targeting PAX6 Expression.
Lu X; Tu H; Tang D; Huang X; Sun F
Curr Eye Res; 2022 Mar; 47(3):418-425. PubMed ID: 34547965
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines.
Xue XB; Xiao CW; Zhang H; Lu AG; Gao W; Zhou ZQ; Guo XL; Zhong MA; Yang Y; Wang CJ
World J Gastroenterol; 2010 Oct; 16(37):4677-84. PubMed ID: 20872968
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma.
Chen W; Wu Y; Liu W; Wang G; Wang X; Yang Y; Chen W; Tai Y; Lu M; Qian Q; Zhang Q; Chen G
Cancer Lett; 2011 Aug; 307(1):93-103. PubMed ID: 21504839
[TBL] [Abstract][Full Text] [Related]
20. Toxicology profiles of a novel p53-armed replication-competent oncolytic adenovirus in rodents, felids, and nonhuman primates.
Su C; Cao H; Tan S; Huang Y; Jia X; Jiang L; Wang K; Chen Y; Long J; Liu X; Wu M; Wu X; Qian Q
Toxicol Sci; 2008 Nov; 106(1):242-50. PubMed ID: 18703561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
